| Lisata Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update |
Globe Newswire |
11/12 |
16:05 |
| EverCommerce Announces Josh McCarter as the Leader of Its EverPro Vertical |
Globe Newswire |
11/12 |
16:05 |
| HF Foods Reports Third Quarter 2024 Financial Results |
Globe Newswire |
11/12 |
16:05 |
| VirTra Reports Third Quarter and Nine Month 2024 Financial Results |
Globe Newswire |
11/12 |
16:05 |
| Inseego Reports Third Quarter 2024 Financial Results |
Globe Newswire |
11/12 |
16:05 |
| ProPhase Labs Announces Closing of Public Offering of Common Stock |
Globe Newswire |
11/12 |
16:05 |
| Better Choice Company Inc. Announces Positive Third Quarter 2024 Results |
Globe Newswire |
11/12 |
16:05 |
| Fulcrum Therapeutics to Participate in the Stifel Healthcare Conference |
Globe Newswire |
11/12 |
16:05 |
| Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights |
Globe Newswire |
11/12 |
16:05 |
| Zevra Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Updates |
Globe Newswire |
11/12 |
16:05 |
| Eyenovia Reports Third Quarter 2024 Financial Results and Provides Corporate Update |
Globe Newswire |
11/12 |
16:05 |
| QIAGEN collaborates with McGill University to advance microbiome research |
Globe Newswire |
11/12 |
16:05 |
| Lexicon Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update |
Globe Newswire |
11/12 |
16:05 |
| PLBY Group Reports Third Quarter 2024 Financial Results |
Globe Newswire |
11/12 |
16:05 |
| SoundThinking Reports Third Quarter 2024 Financial Results |
Globe Newswire |
11/12 |
16:05 |
| AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand |
Globe Newswire |
11/12 |
16:03 |
| STD epidemic slows as new syphilis and gonorrhea cases fall in US |
AP Online |
11/12 |
16:03 |
| Progyny, Inc. Announces Third Quarter 2024 Results |
Globe Newswire |
11/12 |
16:02 |
| Monroe Capital Corporation BDC Announces Third Quarter 2024 Results |
Globe Newswire |
11/12 |
16:01 |
| 89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants |
Globe Newswire |
11/12 |
16:01 |
| Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights |
Globe Newswire |
11/12 |
16:01 |
| Fate Therapeutics Reports Third Quarter 2024 Financial Results and Business Updates |
Globe Newswire |
11/12 |
16:01 |
| Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock |
Globe Newswire |
11/12 |
16:01 |
| Voyager Reports Third Quarter 2024 Financial and Operating Results |
Globe Newswire |
11/12 |
16:01 |
| Beam Therapeutics to Participate in 2024 Jefferies London Healthcare Conference |
Globe Newswire |
11/12 |
16:01 |
